Clinical Trial: Wellbutrin XL for Dysthymic Disorder

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Double-Blind Treatment of Outpatients With Dysthymic Disorder With Wellbutrin XL

Brief Summary: This is a ten-week, double-blind study of Wellbutrin XL in outpatients with dysthymic disorder, a form of low-grade chronic depression. We hypothesize that patients taking Wellbutrin XL will show greater improvement in depression symptoms and psychosocial functioning than patients taking placebo.